173 related articles for article (PubMed ID: 8859003)
1. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
[TBL] [Abstract][Full Text] [Related]
2. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
Sonsalla PK; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine antagonists on methamphetamine-induced dopamine release in high and low alcohol preference rats.
Nishiguchi M; Kinoshita H; Kasuda S; Takahashi M; Yamamura T; Matsui K; Ouchi H; Minami T; Hishida S; Nishio H
Toxicol Mech Methods; 2010 Mar; 20(3):127-32. PubMed ID: 20163290
[TBL] [Abstract][Full Text] [Related]
4. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
5. Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism.
Horner KA; Westwood SC; Hanson GR; Keefe KA
J Pharmacol Exp Ther; 2006 Oct; 319(1):414-21. PubMed ID: 16840646
[TBL] [Abstract][Full Text] [Related]
6. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute and chronic treatment with methamphetamine on mRNA expression of synaptotagmin IV and 25 KDa-synaptic-associated protein in the rat brain.
Isao T; Akiyama K
Psychiatry Clin Neurosci; 2004 Aug; 58(4):410-9. PubMed ID: 15298655
[TBL] [Abstract][Full Text] [Related]
8. [Chronic treatment with nicotine enhances the sensitivity of dopamine autoreceptors that modulate dopamine release from the rat striatum].
Takaki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):335-44. PubMed ID: 7584728
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
Stephans SE; Yamamoto BK
Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
12. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
13. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
Cass WA
J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
[TBL] [Abstract][Full Text] [Related]
14. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality.
Bronstein DM; Hong JS
J Pharmacol Exp Ther; 1995 Aug; 274(2):943-50. PubMed ID: 7636758
[TBL] [Abstract][Full Text] [Related]
16. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
17. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced spectrin proteolysis in the rat striatum.
Staszewski RD; Yamamoto BK
J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
[TBL] [Abstract][Full Text] [Related]
19. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
